Cargando…
Identification of early molecular markers for breast cancer
BACKGROUND: The ductal carcinoma in situ (DCIS) of the mammary gland represents an early, pre-invasive stage in the development of invasive breast carcinoma. Since DCIS is a curable disease, it would be highly desirable to identify molecular markers that allow early detection. Mice transgenic for th...
Autores principales: | Kretschmer, Céline, Sterner-Kock, Anja, Siedentopf, Friederike, Schoenegg, Winfried, Schlag, Peter M, Kemmner, Wolfgang |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045364/ https://www.ncbi.nlm.nih.gov/pubmed/21314937 http://dx.doi.org/10.1186/1476-4598-10-15 |
Ejemplares similares
-
Latent transforming growth factor binding protein 4 (LTBP4) is downregulated in mouse and human DCIS and mammary carcinomas
por: Kretschmer, Celine, et al.
Publicado: (2011) -
Latent Transforming Growth Factor β-Binding Protein 4 Is Downregulated in Esophageal Cancer via Promoter Methylation
por: Bultmann, Insa, et al.
Publicado: (2013) -
Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer – results from the HER-OS patient registry
por: Witzel, Isabell, et al.
Publicado: (2014) -
Trastuzumab in advanced breast cancer – a decade of experience in Germany
por: Jackisch, Christian, et al.
Publicado: (2014) -
High MACC1 expression in combination with mutated KRAS G13 indicates poor survival of colorectal cancer patients
por: Ilm, Katharina, et al.
Publicado: (2015)